Advances in Lung Transplantation & Pulmonary Arterial Hypertension PDF Free Download

Course Title and Number Registration Fee Advances in Lung Transplantation & Pulmonary Arterial Hypertension 2014 M145-6 PAID Fall 2014 Application for Enrollment Please Print Office of Continuing Medical Education, Advances in Lung Transplantation & Pulmonary Arterial Hypertension 2014 Last four digits of your Social Security Number Name First/Middle/Last Male Female Degree Co-Chairs: David J. Ross, MD and Abbas Ardehali, MD Preferred Mailing Address City / State / Zip Expiration Mo/Yr Authorizing Signature Mail to: UCLA Office of Continuing Medical Education,, Lung Transplantation 2014, 10920 Wilshire Blvd., Suite 1060, Los Angeles, CA 90024-6512 Fax to: 310 794-2624 must include charge card information and authorizing signature Call: 310 794-2620 Register online: www.cme.ucla.edu/courses click on Advances in Lung Transplantation & Pulmonary Arterial Hypertension 2014 Office of Continuing Medical Education, American Express Los Angeles, CA 90095-6938 Discover 405 Hilgard Avenue MC29 Card Number Visa MasterCard UCLA Office of Continuing Medical Education Charge: cme.ucla.edu/courses Check enclosed payable to: The Regents of the University of California Register today! E-Mail Address Enroll now by mail, fax, phone or online. Area Code Fax Area Code Phone Advances in Lung Transplantation & Ronald Reagan UCLA Medical Center Los Angeles, California

Advances in Lung Transplantation & Course Description The course encompasses a multidisciplinary update which focus on recent advances in the fields of both pulmonary arterial hypertension PAH and lung transplantation. Recent developments in pathophysiology, clinical diagnosis and the burgeoning array of novel pharmacologic treatment options will be emphasized for the spectrum of causes of pulmonary vascular disease. In addition, newly FDA-approved pharmacologic and update on surgical treatment options for patients with chronic thromboembolic pulmonary hypertension CTEPH will be reviewed. Recent advances in clinical success of Lung Transplantation have culminated in its application to an increasing spectrum of complex patients suffering from Scleroderma, pulmonary hypertension, prior malignancy, pulmonary graft-versus-host disease and pulmonary fibrosis. Patients previously denied for transplantation on the basis of cardiac disease, are now considered appropriate for combined procedures of cardiac repair concurrent with transplantation. Further, advanced pulmonary disease with cardiopulmonary failure may now be bridged with extra-corporeal membrane oxygenation ECMO to successful lung or heart-lung transplantation. Efforts to expand donor availability now encompass the novel breathing lung technology ex vivo perfusion and ventilation to optimize allograft function and potential suitability for transplant. To respond to an increasing emphasis for patients to receive concurrent medical care at a distance from the transplant centers, within community-based and managed care environments, the course will also provide to the Practitioner, a primer for diagnosis, management of complications, Immunology and pharmacology as relevant to such challenging patients. Target Audience This course will target practicing Pulmonologists, Cardiologists, Family Practitioners, Internal Medicine and other allied professionals. Goals and Objectives At the conclusion of this activity, participants will be able to: Recognize the latest advances in the field of lung and heart-lung transplantation, including: patient selection, detection of allograft rejection, immunosuppressive strategies, Immunogenetics and novel modes of allograft preservation. Recognize new pathologic mechanisms implicated in pulmonary arterial hypertension, state of the art pharmacologic therapies available for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary arterial hypertension CTEPH Identify how these treatment strategies can be applied to clinical practice and improve outcomes. General Information November 15, 2014 Course Fees Location Ronald Reagan Medical Center UCLA 757 Westwood Plaza Los Angeles, CA 90095 Accreditation Statement The Office of Continuing Medical Education, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Office of Continuing Medical Education,, designates this live activity for a maximum of 7 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure Statement The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is truly independent and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program s participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.

Saturday, November 15th, 2014 7:00 Registration & Breakfast 7:55 Welcome and Introduction David Ross, MD 8:00 Transplant Immunology: A Primer for the Clinician Elaine Reed, PhD 8:30 Immunosuppresive Therapies after Lung David Sayah, MD, PhD Transplantation: An Evolution of Clinical Protocols 9:00 Bench-to-Bedside: Chemokines & Molecular Targets John Belperio, MD for Potential Intervention after Lung Transplant 9:30 Expanding the Donor Pool: Ex Vivo Lung Preservation Abbas Ardehali, MD 10:00 Round Table Discussion/ Questions 10:15 Break 10:30 Expanding Recipient Criteria for Lung Transplant: Rajan Saggar, MD The Scleroderma Experience 11:00 Controversies in Patient Candidacy Ariss Der Hovanessian, MD 11:30 Cardiac Repair: Strategies Concurrent with Abbas Ardehali, MD Lung Transplant 12:00 The Microbial Milieu: Strategies After Bernard Kubak, MD Lung Transplantation 12:30 Extra-Corporeal Membrane Oxygenation ECMO Reshma Biniwale, MD as Bridge to Lung Transplantation : Clinical Considerations 1:00 Round Table Discussion / Questions 1:15 Lunch 2:15 Novel Echocardiographic Indices for Assessment: Jamil Aboulhosn, MD Pulmonary Arterial Hypertension PAH 2:45 Update on New FDA-Approved Therapies for PAH David Ross, MD 3:15 Thoracic Imaging: Implications for PAH Scott Genshaft, MD Evaluation & Treatment 3:45 Bench-to-Bedside: Novel Mechanisms in PAH Mansoureh Eghbali, PhD 4:15 Pulmonary Endarterectomy PE & Therapies for David Ross, MD Chronic Thromboembolic Pulmonary Hypertension CTEPH 4:45 Round Table Discussion / Questions 5:00 Adjourn

COURSE CHAIRS David J. Ross, MD Medical Director, Lung & Heart-Lung Transplant Program Director, Pulmonary Hypertension & Thromboendarterectomy Program Professor of Medicine, UCLA Abbas Ardehali, MD, FACS Professor of Surgery and Medicine William E. Connor Chair in Cardiothoracic Transplantation Director, UCLA Heart, Lung and Heart-Lung Transplant Program COURSE FACULTY Jamil Aboulhosn, MD Assistant Clinical Professor Department of Medicine Ahmanson/UCLA Adult Congenital Heart Disease Center Pulmonary Thromboendartecrectomy Program John Belperio, MD Associate Professor of Medicine Division of Pulmonary and Critical Care Medicine Reshma Biniwale, MD Assistant Professor of Surgery Pediatric Cardiology, Thoracic and Cardiac Surgery Ariss Der Hovanessian, MD Physician, Pulmonary and Critical Care Medicine Mansoureh Eghbali, PhD Assistant Professor Department of Anesthesiology, UCLA Scott Genshaft, MD Assistant Professor of Radiology Bernard Kubak, MD, PhD Professor, Department of Medicine Clinical Professor, Infectious Disease Elaine Reed, PhD Director, UCLA Immunogenetics Center Professor, Pathology & Laboratory Medicine Transplantation Immunology, Signal Transduction Rajan Saggar, MD MICU Director Assistant Professor of Medicine Heart-Lung Transplant & Pulmonary Hypertension Programs David Sayah, MD, PhD Clinical Instructor Division of Pulmonary & Critical Care Medicine Early registration is recommended, as space is limited. Directions: From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. The Ronald Reagan UCLA Medical Center is located on the corner of Westwood Plaza and Charles E. Young Dr. South. Parking: Please park in lot 8. A Parking attendant will be on duty from 7:00-9:00 AM. If you arrive outside of this time frame, please report to the parking kiosk on Westwood Plaza to pay for your parking permit. Participants are to pay their own parking charges at a rate of $12 per vehicle. Refunds: Cancellations must be received in writing by Wednesday, October 15, 2014 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. Enrollment: Online: Go to www.cme.ucla.edu/courses and click on Advances in Lung Transplantation and Pulmonary Arterial Hypertension 2014. You may use your MasterCard, Visa, American Express or Discover card to register. By Mail: Use the form attached. Mail to the UCLA Office of Continuing Medical Education, David Geffen School of Medicine at UCLA, Lung Transplantation 2014, 10920 Wilshire Blvd., Suite 1060, Los Angeles, CA 90024-6512 By Fax: Send the completed enrollment form with credit card information and authorizing signature. Fax to : 310 794-2624 By Phone: Use your Mastercard, VISA, or Discover Card. Call 310 794-2620 Please visit our website for other UCLA CME offerings. www.cme.ucla.edu